معرفی
Abhinav Sharma, MD, PhD is an Assistant Professor in the Department of Medicine, Division of Cardiology at McGill University and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), where he is affiliated with the Centre for Outcomes Research and Evaluation (CORE) and the Cardiovascular Health Across the Lifespan program.
Education & Training
While specific degrees are not detailed in the supplied text, his dual MD and PhD credentials indicate combined clinical and research training, most likely in medicine and either epidemiology, health-informatics or cardiovascular sciences.
Research Interests
Dr Sharma’s work centres on digital health and precision cardiovascular medicine. His team investigates:
- Mobile-health and remote-monitoring technologies to drive behaviour change and improve clinical outcomes in heart failure and diabetes.
- Artificial-intelligence–driven digital biomarkers and voice-assistant systems for scalable clinical screening.
- Large-scale secondary analyses of landmark trials (CANVAS, CREDENCE, EMPA-REG, EXAMINE, TOPCAT) to dissect heterogeneous cardiovascular phenotypes, sex-specific responses and regulatory implications.
Publication Trends
Across >100 manuscripts since 2018, three thematic arcs emerge:
- Pharmacotherapy Trials & Meta-analyses evaluating SGLT2 inhibitors, GLP-1 receptor agonists and mineralocorticoid antagonists across heart-failure and diabetic cohorts.
- Digital-Health Intervention Studies including RCT protocols (TARGET-HF-DM, DECIDE-CV) and validation of AI voice-screening for COVID-19 exposure in cardiology clinics.
- Precision-Medicine Analytics employing unsupervised machine-learning to delineate phenotypic clusters predictive of cardiovascular and renal events.
Scientific Awards & Recognition
No specific honours or prizes are listed in the provided text.
Grants & Clinical Trials
Dr Sharma is principal architect of several multicentre programmes:
- TARGET-HF-DM – mobile-health intervention to enhance physical activity and medication adherence in heart failure with comorbid diabetes.
- DECIDE-CV – synchronous telehealth model for integrated cardiorenal care in type 2 diabetes.
- SOGALDI-PEF – factorial RCT of SGLT2 inhibition ± aldosterone antagonism in heart failure with preserved ejection fraction.
Laboratory & Collaborations
Operating within the RI-MUHC ecosystem, his research group leverages the institute’s Technology Platforms (Bioinformatics, Clinical Informatics, Proteomics, Small-Animal Imaging) and maintains partnerships across McGill’s Department of Epidemiology, the MUHC cardiac e-health clinic, and international consortia such as the Heart Failure Collaboratory (HFC) and the Academic Research Consortium (ARC).
